MedTrace Logo

Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer

NCT06346093 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2025-06-10

No results posted yet for this study

Summary

This study is a randomized, double-blind and placebo-controlled study. The purpose of this study is to evaluate the efficacy and safety of FMT capsules combined with chemotherapy and anti-PD1/PDL1 therapy in the advanced gastric cancer.

Conditions

  • Advanced Gastric Cancer

Interventions

PROCEDURE

Fecal Microbiota Transplantation Capsules

FMT Capsules in Combination with Chemotherapy and Anti-PD1/PD-L1 Therapy

PROCEDURE

Placebo

Mainly composed of starch, the appearance, shape, color, and size are exactly the same as FMT capsules

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-02
Primary Completion
2030-06-30
Completion
2030-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06346093 on ClinicalTrials.gov